Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Lateral internal sphincterotomy (LIS) using endoanal ultrasound - A Video Vignette

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway.

PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation).

RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76).

CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks.

Original languageEnglish
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue number1
Pages (from-to)66-78
Number of pages13
Publication statusPublished - 1 Jan 2021

Bibliographical note

Publisher Copyright:
Copyright © 2020 American Society of Clinical Oncology. All rights reserved.

Copyright 2021 Elsevier B.V., All rights reserved.

ID: 61702767